Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - astragalus membranaceus,avena sativa,betacarotene,biotin,calcium ascorbate dihydrate,calcium carbonate,calcium pantothenate,choline bitartrate,chromium picolinate,colecalciferol,copper gluconate,cyanocobalamin,camellia sinensis,centella asiatica,citrus bioflavonoids extract,crataegus laevigata,cynara scolymus,d-alpha-tocopheryl acid succinate,ferrous fumarate,folic acid,ginkgo biloba,heavy magnesium oxide,inositol,lycopene,lysine hydrochloride,manganese amino acid chelate,nicotinamide,potassium -

Australia - English - Department of Health (Therapeutic Goods Administration)

culpan medical pty ltd - 38426 - brachytherapy applicator, manual, prostate - intended to stabilize the prostate and provide access for insertion of isotopes (seeds) into the prostate.

Australia - English - Department of Health (Therapeutic Goods Administration)

meditron pty ltd - 38426 - brachytherapy applicator, manual, prostate - a manual brachytherapy applicator specifically designed to be used in radiation therapy treatments of the prostate.

United States - English - NLM (National Library of Medicine)

method pharmaceuticals, llc - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin 600 mg - gabapentin is indicated for: - adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy       gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. pregnancy category c :  there are no adequate and well-controlled studies in pregnant women. in nonclinical studies in mice, rats, and rabbits, gabapentin was developmentally toxic when administered to pregnant animals at doses similar to or lower than those used clinically. gabapentin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. when pregnant mice received oral doses of gabapentin (500 mg/kg/day, 1,000 mg/kg/day, or 3,000 mg/kg/day) during the period of organogenesis, embryo-fetal toxicity (increased incidences of skeletal variations) was observed at the two highest doses. the no-effect dose for embryo-fetal developmental toxicity in

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - olanzapine (unii: n7u69t4szr) (olanzapine - unii:n7u69t4szr) - olanzapine 2.5 mg - olanzapine tablets are indicated for the treatment of schizophrenia. efficacy was established in three clinical trials in adult patients with schizophrenia: two 6 week trials and one maintenance trial. in adolescent patients with schizophrenia (ages 13 to 17), efficacy was established in one 6 week trial [see clinical studies (14.1) ]. when deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see warnings and precautions ( 5.5 ) ]. olanzapine tablets are indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder and maintenance treatment of bipolar i disorder. efficacy was established in three clinical trials in adult patients with manic or mixed episo

United States - English - NLM (National Library of Medicine)

avpak - olanzapine (unii: n7u69t4szr) (olanzapine - unii:n7u69t4szr) - olanzapine 2.5 mg - olanzapine tablets, usp are indicated for the treatment of schizophrenia. efficacy was established in three clinical trials in adult patients with schizophrenia: two 6-week trials and one maintenance trial. in adolescent patients with schizophrenia (ages 13 to 17), efficacy was established in one 6-week trial [see clinical studies ( 14.1)] . when deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see warnings and precautions ( 5.4)]. monotherapy — olanzapine tablets, usp are indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder and maintenance treatment of bipolar i

United States - English - NLM (National Library of Medicine)

app pharmaceuticals, llc - penicillin g potassium (unii: vl775zth4c) (penicillin g - unii:q42t66vg0c) - penicillin g 5000000 [iu]

United States - English - NLM (National Library of Medicine)

apotheca company - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj), sus scrofa adrenal gland (unii: 398iyq16yv) (sus scrofa adrenal gland - unii:398iyq16yv), sus scrofa hypothalamus (unii: n6r0856z79) (sus scrofa hypothalamus - unii:n6r0856z79), sus scrofa pituitary gland (unii: e8s87o660t) (sus scrofa pituitary gland - unii:e8s87o660t), sus scrofa prostate (unii: o6ud3347k2) (sus scrofa prostate - unii:o6ud3347k2), testosterone (unii: 3xmk78s47o) (testosterone - unii:3xmk78s47o), chelidonium majus - hydrocortisone 6 [hp_c] in 1 ml - homeopathic indications:   for the temporary relief of the following complaints:  pain in spermatic cord, testicles, liver and prostate. indications:   for the temporary relief of the following complaints:  pain in spermatic cord, testicles, liver, and prostate.

United States - English - NLM (National Library of Medicine)

apotheca company - herring sperm dna (unii: 51fi676n6f) (herring sperm dna - unii:51fi676n6f), saccharomyces cerevisiae rna (unii: j17gbz5vgx) (saccharomyces cerevisiae rna - unii:j17gbz5vgx), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj), sus scrofa hypothalamus (unii: n6r0856z79) (sus scrofa hypothalamus - unii:n6r0856z79), sus scrofa pituitary gland (unii: e8s87o660t) (sus scrofa pituitary gland - unii:e8s87o660t), sus scrofa prostate (unii: o6ud3347k2) (sus scrofa prostate - unii:o6ud3347k2), - herring sperm dna 6 [hp_x] in 1 ml - homeopathic indications: for the temporary relief of the following complaints; pain in spermatic cord, testicular, liver, and prostate.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - american ginseng (unii: 8w75vcv53q) (american ginseng - unii:8w75vcv53q), chaste tree (unii: 433osf3u8a) (chaste tree - unii:433osf3u8a), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), dieffenbachia seguine (unii: 01800c6e6b) (dieffenbachia seguine - unii:01800c6e6b), potassium bromide (unii: osd78555zm) (bromide ion - unii:952902ix06), strychnine phosphate dihydrate (unii: td67syy51d) (strychnine - unii:h9y79vd43j), lytta vesicatoria (unii: 3q034ro3bt) (lytta vesicatoria - unii:3q034ro - american ginseng 4 [hp_x] in 1 ml - temporary relief of symptoms related to male hormonal problems such as libido difficulties, fatigue, urinary problems related to bladder, prostate and depression.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. temporary relief of symptoms related to male hormonal problems such as libido difficulties, fatigue, urinary problems related to bladder, prostate and depression.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.